Vycor Medical (VYCO) Income from Discontinued Operations (2019 - 2026)
Vycor Medical's (VYCO) quarterly Income from Discontinued Operations came in at -$3179.0 in Q2 2026, down 74.1% year-over-year from -$12272.4 in Q2 2025, and down 24553.85% quarter-over-quarter from $13.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Income from Discontinued Operations (2019 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Income from Discontinued Operations for 8 consecutive years, with -$3179.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Discontinued Operations fell 74.1% year-over-year to -$3179.0 in Q2 2026; TTM through Jun 2026 was -$3527.0, a 78.67% decrease from a year earlier, with the FY2025 full-year figure at -$2236.0, down 797.99% from the prior year.
- Income from Discontinued Operations was -$3179.0 for Q2 2026 at Vycor Medical, down from $13.0 in the prior quarter.
- Over five years, Income from Discontinued Operations peaked at $13.0 in Q1 2026 and troughed at -$3179.0 in Q2 2026.
- A 5-year average of -$970.78 and a median of -$551.5 in 2022 frame the typical range for Income from Discontinued Operations.
- Across the five-year window, Income from Discontinued Operations tumbled 3626.53% in 2025 and soared 126.53% in 2026, its largest moves.
- Over 5 years, Income from Discontinued Operations stood at -$678.0 in 2022, then sank by 356.34% to -$3094.0 in 2023, then soared by 98.32% to -$52.0 in 2024, then plunged by 490.38% to -$307.0 in 2025, then slumped by 935.5% to -$3179.0 in 2026.
- The last three Income from Discontinued Operations figures came in at -$3179.0 (Q2 2026), $13.0 (Q1 2026), and -$307.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -3,179.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,179.00 |
| Mar 31, 2026 | 13.00 |
| Dec 31, 2025 | -307.00 |
| Sep 30, 2025 | -54.00 |
| Jun 30, 2025 | -1,826.00 |
| Mar 31, 2025 | -49.00 |
| Dec 31, 2024 | -52.00 |
| Sep 30, 2024 | -47.00 |
| Jun 30, 2024 | -49.00 |
| Mar 31, 2024 | -101.00 |
| Dec 31, 2023 | -3,094.00 |
| Sep 30, 2023 | -425.00 |
| Jun 30, 2023 | -2,385.00 |
| Mar 31, 2023 | -707.00 |
| Dec 31, 2022 | -678.00 |
| Sep 30, 2022 | -2,495.00 |
| Jun 30, 2022 | -1,284.00 |
| Mar 31, 2022 | -755.00 |
| Dec 31, 2021 | -958.00 |
| Sep 30, 2021 | -3,966.00 |